Clinical trial
An Open-label Extension of Study AC-066A401 Investigating the Safety and Tolerability of ACT-385781A Compared to Flolan® in Injectable Prostanoid Treatment-naïve Patients With Pulmonary Arterial Hypertension (PAH)
NCT01105117 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Extension of Study AC-066A401 Investigating the Safety and Tolerability of ACT-385781A Compared to Flolan® in Injectable Prostanoid Treatment-naïve Patients With Pulmonary Arterial Hypertension (PAH)
- Lead sponsor
- Actelion
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- December 31, 2011
- Enrollment
- 2 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.